scholarly article | Q13442814 |
P2093 | author name string | Lingling Xu | |
Yaoming Xue | |||
Meiping Guan | |||
Jimin Li | |||
Chenzhong Li | |||
Yanmei Zeng | |||
Zhongji Zheng | |||
P2860 | cites work | Activation of AMPK by bitter melon triterpenoids involves CaMKKβ | Q28486994 |
Citrullus lanatus 'sentinel' (watermelon) extract reduces atherosclerosis in LDL receptor-deficient mice | Q30558177 | ||
Role of inflammatory mediators in thrombogenesis | Q34542369 | ||
Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation | Q35086140 | ||
Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. | Q35103622 | ||
Anti-inflammatory effect of Momordica charantia in sepsis mice | Q35231058 | ||
The role of triglycerides in atherosclerosis | Q35602424 | ||
Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cells | Q36738086 | ||
Protective effects of AMP‐activated protein kinase in the cardiovascular system | Q37793322 | ||
Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation. | Q38779824 | ||
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS. | Q39000699 | ||
Does bitter melon contain an activator of AMP-activated kinase? | Q39231648 | ||
Genetics of Triglycerides and the Risk of Atherosclerosis | Q39324048 | ||
EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner | Q39334183 | ||
AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. | Q39469473 | ||
Activating effect of momordin, extract of bitter melon (Momordica Charantia L.), on the promoter of human PPARdelta | Q39759452 | ||
A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase | Q39957131 | ||
Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice | Q42711552 | ||
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway | Q42815451 | ||
Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantia | Q46122437 | ||
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition. | Q47226159 | ||
Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice | Q47578369 | ||
Regression of atherosclerosis: lessons learned from genetically modified mouse models | Q49709124 | ||
Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. | Q51050646 | ||
Relationship between serum triglyceride levels and endothelial function in a large community-based study. | Q51377710 | ||
Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring. | Q51430168 | ||
Soluble adhesion molecules and the search for biomarkers for atherosclerosis | Q74605910 | ||
Mechanisms underlying decreased hepatic triacylglycerol and cholesterol by dietary bitter melon extract in the rat | Q83762705 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Momordica charantia | Q428750 |
atherosclerosis | Q12252367 | ||
triglyceride | Q186319 | ||
P304 | page(s) | 251 | |
P577 | publication date | 2018-11-06 | |
P1433 | published in | Lipids in Health and Disease | Q15756695 |
P1476 | title | Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation | |
P478 | volume | 17 |
Q64257123 | , a Nutraceutical Approach for Inflammatory Related Diseases | cites work | P2860 |